Want to see GB:BVC full AI Analyst Report?
BVC Stock Chart & Stats
11.85 p
-0.05 p(-0.39%)
At close: 4:00 PM EDT
11.85 p
-0.05 p(-0.39%)
Day’s Range― - ―
52-Week Range10.60 p - 20.00 p
Previous CloseN/A
Volume199.55K
Average Volume (3M)173.51K
Market Cap
£38.26M
Enterprise Value59.64M
Total Cash (Recent Filing)£22.50M
Total Debt (Recent Filing)£10.53M
Price to Earnings (P/E)―
Beta0.37
Next Earnings
Mar 17, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.96%
Share Statistics
EPS (TTM)-0.04
Shares Outstanding436,874,180
10 Day Avg. Volume194,247
30 Day Avg. Volume173,514
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)1.44
Price to Sales (P/S)0.75
P/FCF Ratio-10.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)£95.10M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthRevenue has returned to growth and accelerated meaningfully in 2025, indicating improving demand across the company’s offerings. If sustained, this top-line recovery can support better operating leverage, broader customer adoption, and stronger capacity to fund product development and commercial expansion.
Conservative LeverageLow debt relative to equity gives BATM more financial flexibility than a highly leveraged business and limits the burden of interest and refinancing obligations. This conservative capital structure can help the company withstand operating volatility while preserving options to invest in networking and cybersecurity growth.
Diversified Technology ModelBATM operates across two related technology businesses and sells to multiple customer groups, reducing reliance on a single product category or end market. Its mix of product sales, software, support, maintenance, and professional services also creates opportunities for repeat and recurring revenue.
Bears Say
Persistent Net LossesLarge net losses in both 2024 and 2025 show that revenue recovery has not yet translated into durable profitability. Continued losses can constrain reinvestment, weaken financial resilience, and make earnings quality dependent on a successful improvement in margins and operating execution.
Negative Cash GenerationRecent negative operating and free cash flow indicates that the business is consuming cash despite its technology sales base. If this persists, BATM may have less internally generated funding for development and expansion, while sustained cash use could eventually pressure liquidity and capital allocation.
Eroding Equity BaseThe substantial decline in shareholders’ equity is consistent with the company’s multi-year losses and reduces the balance-sheet cushion available to absorb further underperformance. Negative returns on equity in 2024–2025 reinforce the concern that capital is not currently producing sustainable shareholder returns.
BATM Advanced Communications News
BVC FAQ
What was BATM Advanced Communications’s price range in the past 12 months?
BATM Advanced Communications lowest share price was 10.60 p and its highest was 20.00 p in the past 12 months.
What is BATM Advanced Communications’s market cap?
BATM Advanced Communications’s market cap is £38.26M.
When is BATM Advanced Communications’s upcoming earnings report date?
BATM Advanced Communications’s upcoming earnings report date is Mar 17, 2027 which is in 158 days.
How were BATM Advanced Communications’s earnings last quarter?
BATM Advanced Communications released its earnings results on Aug 24, 2026. The company reported -0.004 p earnings per share for the quarter.
Is BATM Advanced Communications overvalued?
According to Wall Street analysts BATM Advanced Communications’s price is currently Overvalued.
Does BATM Advanced Communications pay dividends?
BATM Advanced Communications pays a Notavailable dividend of 0.74 p which represents an annual dividend yield of 0.96%. See more information on BATM Advanced Communications dividends here
What is BATM Advanced Communications’s EPS estimate?
BATM Advanced Communications’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BATM Advanced Communications have?
BATM Advanced Communications has 436,874,180 shares outstanding.
What happened to BATM Advanced Communications’s price movement after its last earnings report?
BATM Advanced Communications reported an EPS of -0.004 p in its last earnings report. Following the earnings report the stock price went up 0.422%.
Which hedge fund is a major shareholder of BATM Advanced Communications?
Currently, no hedge funds are holding shares in GB:BVC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BATM Advanced Communications Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Company Description
BATM Advanced Communications
BATM Advanced Communications Ltd., together with its various group companies, delivers cutting-edge real-time technologies for both sophisticated networking solutions and advanced biomedical systems. The company operates across Israel, the United States, and Europe. It is structured into two primary business units: Networking and Cyber, and Bio-Medical. The Networking and Cyber division oversees the research, development, manufacturing, and marketing of data communication products. Its key offerings include network function virtualization, carrier Ethernet and MPLS access technologies, and systems for cyber network monitoring. This segment also provides a range of software services, such as training, technical assistance, and laboratory maintenance, in addition to undertaking construction contracts. Conversely, the Bio-Medical division concentrates on the innovation, production, commercialization, and distribution of medical products, with a particular emphasis on laboratory diagnostics and sterilization equipment. Its portfolio features molecular biology diagnostic tools and specialized systems for managing pathogenic and medical waste in critical environments like laboratories, hospitals, pharmaceutical manufacturing plants, and agricultural settings. This division also acts as a distributor for a broad array of diagnostic apparatus and medical consumables from various manufacturers. Notably, BATM has entered into a significant partnership with Novamed Ltd to collaboratively develop and market a home-use testing kit for COVID-19. Established in 1992, the company's corporate headquarters are situated in Hod Hasharon, Israel.
Technical Analysis
EKF Diagnostics Holdings
―
Omega Diagnostics
―
Renalytix
―
Diaceutics
―
Abingdon Health PLC
―







